A phase I trial of LBS 008 for the treatment of Stargardt disease

Trial Profile

A phase I trial of LBS 008 for the treatment of Stargardt disease

Planning
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2017

At a glance

  • Drugs LBS 008 (Primary)
  • Indications Stargardt disease
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Jan 2017 New trial record
    • 06 Jan 2017 According to a Lin Bioscience media release, this trial is expected to begin in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top